Revision of Previously Issued Consolidated Financial Statements - Impact of revision (Details) - USD ($)	3 Months Ended			6 Months Ended
	Jun. 30, 2024	Mar. 31, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023	Mar. 31, 2023	Dec. 31, 2022
Consolidated Balance Sheet
Losses in excess of investment in unconsolidated joint venture		$ 0
Total liabilities	$ 2,641,000	2,713,000		$ 2,641,000		$ 277,556,000
Accumulated deficit	(88,778,000)	(87,052,000)		(88,778,000)		(95,905,000)
Total stockholders' equity	1,826,000	3,450,000	$ 10,494,000	1,826,000	$ 10,494,000	(10,048,000)	$ 21,180,000	$ 27,341,000
Total liabilities and stockholders' equity (deficit)	4,467,000	6,163,000		4,467,000		$ 267,508,000
Consolidated Statement of Operations and Comprehensive Income
Equity in net loss from unconsolidated joint venture		(5,962,000)		(5,962,000)	(4,000)
Income before taxes	(1,672,000)	8,939,000	(10,869,000)	7,267,000	(16,981,000)
Net Income (Loss)	(1,726,000)	8,853,000	(10,920,000)	7,127,000	(17,156,000)
Comprehensive income attributable to common stockholders	$ (1,606,000)	$ 8,973,000	$ (10,802,000)	$ 7,367,000	$ (16,919,000)
Income per share - basic	$ (0.03)	$ 0.17	$ (0.29)	$ 0.12	$ (0.45)
Income per share - diluted	$ (0.03)	$ 0.17	$ (0.29)	$ 0.12	$ (0.45)
Consolidated Statement of Cash Flows
Net Income (Loss)	$ (1,726,000)	$ 8,853,000	$ (10,920,000)	$ 7,127,000	$ (17,156,000)
Equity in net loss from unconsolidated joint venture		5,962,000		5,962,000	4,000
Net cash used in operating activities		(4,454,000)		$ (5,845,000)	$ 1,820,000
As Previously Reported
Consolidated Balance Sheet
Losses in excess of investment in unconsolidated joint venture		792,000
Total liabilities		3,505,000
Accumulated deficit		(87,844,000)
Total stockholders' equity		2,658,000
Total liabilities and stockholders' equity (deficit)		6,163,000
Consolidated Statement of Operations and Comprehensive Income
Equity in net loss from unconsolidated joint venture		(6,754,000)
Income before taxes		8,147,000
Net Income (Loss)		8,061,000
Comprehensive income attributable to common stockholders		$ 8,181,000
Income per share - basic		$ 0.15
Income per share - diluted		$ 0.15
Consolidated Statement of Cash Flows
Net Income (Loss)		$ 8,061,000
Equity in net loss from unconsolidated joint venture		6,754,000
Net cash used in operating activities		(4,454,000)
Error Related to Accounting for Equity Method Investment | Revision Impact
Consolidated Balance Sheet
Losses in excess of investment in unconsolidated joint venture		(792,000)
Total liabilities		(792,000)
Accumulated deficit		792,000
Total stockholders' equity		792,000
Consolidated Statement of Operations and Comprehensive Income
Equity in net loss from unconsolidated joint venture		792,000
Income before taxes		792,000
Net Income (Loss)		792,000
Comprehensive income attributable to common stockholders		$ 792,000
Income per share - basic		$ 0.02
Income per share - diluted		$ 0.02
Consolidated Statement of Cash Flows
Net Income (Loss)		$ 792,000
Equity in net loss from unconsolidated joint venture		$ (792,000)